|
1
|
Mathers CD and Loncar D: Projections of
global mortality and burden of disease from 2002 to 2030. PLoS Med.
3:e4422006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Patange AR, Valentini RP, Gothe MP, Du W
and Pettersen MD: Vitamin D deficiency is associated with increased
left ventricular mass and diastolic dysfunction in children with
chronic kidney disease. Pediatr Cardiol. 34:536–542. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Berenson GS, Srinivasan SR, Bao W, Newman
WP III, Tracy RE and Wattigney WA: Association between multiple
cardiovascular risk factors and atherosclerosis in children and
young adults. The Bogalusa Heart Study. N Engl J Med.
338:1650–1656. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lauer RM and Clarke WR: Use of cholesterol
measurements in childhood for the prediction of adult
hypercholesterolemia. The Muscatine Study. JAMA. 264:3034–3038.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Holick MF: Vitamin D deficiency. N Engl J
Med. 357:266–281. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rose G: Cold weather and ischaemic heart
disease. Br J Prev Soc Med. 20:97–100. 1966.PubMed/NCBI
|
|
7
|
Fleck A: Latitude and ischaemic heart
disease. Lancet. 1:6131989. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang L, Song Y, Manson JE, Pilz S, März W,
Michaëlsson K, Lundqvist A, Jassal SK, Barrett-Connor E, Zhang C,
et al: Circulating 25-hydroxy-vitamin D and risk of cardiovascular
disease: a meta-analysis of prospective studies. Circ Cardiovasc
Qual Outcomes. 5:819–829. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Williams DM, Fraser A, Sayers A, Fraser
WD, Hingorani A, Deanfield J, Smith Davey G, Sattar N and Lawlor
DA: Associations of 25-hydroxyvitamin D2 and D3 with cardiovascular
risk factors in childhood: Cross-sectional findings from the Avon
Longitudinal Study of Parents and Children. J Clin Endocrinol
Metab. 97:1563–1571. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Andersson P, Rydberg E and Willenheimer R:
Primary hyperparathyroidism and heart disease - a review. Eur Heart
J. 25:1776–1787. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xiang W, Kong J, Chen S, Cao LP, Qiao G,
Zheng W, Liu W, Li X, Gardner DG and Li YC: Cardiac hypertrophy in
vitamin D receptor knockout mice: role of the systemic and cardiac
renin-angiotensin systems. Am J Physiol Endocrinol Metab.
288:E125–E132. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lind L, Hänni A, Lithell H, Hvarfner A,
Sörensen OH and Ljunghall S: Vitamin D is related to blood pressure
and other cardiovascular risk factors in middle-aged men. Am J
Hypertens. 8:894–901. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
O'Connell TD, Berry JE, Jarvis AK,
Somerman MJ and Simpson RU: 1,25-Dihydroxyvitamin D3 regulation of
cardiac myocyte proliferation and hypertrophy. Am J Physiol.
272:H1751–H1758. 1997.PubMed/NCBI
|
|
14
|
Bae S, Singh SS, Yu H, Lee JY, Cho BR and
Kang PM: Vitamin D signaling pathway plays an important role in the
development of heart failure after myocardial infarction. J Appl
Physiol (1985). 114:979–987. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Raitakari OT, Juonala M, Kähönen M,
Taittonen L, Laitinen T, Mäki-Torkko N, Järvisalo MJ, Uhari M,
Jokinen E, Rönnemaa T, et al: Cardiovascular risk factors in
childhood and carotid artery intima-media thickness in adulthood:
the Cardiovascular Risk in Young Finns Study. JAMA. 290:2277–2283.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Birken CS, Lebovic G, Anderson LN,
McCrindle BW, Mamdani M, Kandasamy S, Khovratovich M, Parkin PC and
Maguire JL: TARGet Kids! collaboration: Association between Vitamin
D and Circulating Lipids in Early Childhood. PLoS One.
10:e01319382015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Karalius VP, Zinn D, Wu J, Cao G, Minutti
C, Luke A, Kramer H and Durazo-Arvizu R: Prevalence of risk of
deficiency and inadequacy of 25-hydroxyvitamin D in US children:
NHANES 2003–2006. J Pediatr Endocrinol Metab. 27:461–466. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jones G: Pharmacokinetics of vitamin D
toxicity. Am J Clin Nutr. 88:582S–586S. 2008.PubMed/NCBI
|
|
19
|
Carpenter TO, Zhang JH, Parra E, Ellis BK,
Simpson C, Lee WM, Balko J, Fu L, Wong BY and Cole DE: Vitamin D
binding protein is a key determinant of 25-hydroxyvitamin D levels
in infants and toddlers. J Bone Miner Res. 28:213–221. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kendrick J, Targher G, Smits G and
Chonchol M: 25-Hydroxyvitamin D deficiency is independently
associated with cardiovascular disease in the Third National Health
and Nutrition Examination Survey. Atherosclerosis. 205:255–260.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Marniemi J, Alanen E, Impivaara O,
Seppänen R, Hakala P, Rajala T and Rönnemaa T: Dietary and serum
vitamins and minerals as predictors of myocardial infarction and
stroke in elderly subjects. Nutr Metab Cardiovasc Dis. 15:188–197.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shedeed SA: Vitamin D supplementation in
infants with chronic congestive heart failure. Pediatr Cardiol.
33:713–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Stagi S, Rigante D, Lepri G, Cerinic
Matucci M and Falcini F: Severe vitamin D deficiency in patients
with Kawasaki disease: a potential role in the risk to develop
heart vascular abnormalities? Clin Rheumatol. May 22–2015.(Epub
ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kudo K, Hasegawa S, Suzuki Y, Hirano R,
Wakiguchi H, Kittaka S and Ichiyama T: 1α,25-Dihydroxyvitamin D(3)
inhibits vascular cellular adhesion molecule-1 expression and
interleukin-8 production in human coronary arterial endothelial
cells. J Steroid Biochem Mol Biol. 132:290–294. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jamieson N and Singh-Grewal D: Kawasaki
disease: A clinician's update. Int J Pediatr. 2013:6453912013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Williams DM, Fraser A, Sayers A, Fraser
WD, Hyppönen E, Smith GD, Sattar N and Lawlor DA: Associations of
childhood 25-hydroxyvitamin D2 and D3 and cardiovascular risk
factors in adolescence: prospective findings from the Avon
Longitudinal Study of Parents and Children. Eur J Prev Cardiol.
21:281–290. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vimaleswaran KS, Cavadino A and Berry DJ:
Association of vitamin D status with arterial blood pressure and
hypertension risk: a mendelian randomisation study. Lancet Diabetes
Endocrinol. 2:719–729. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dong Y, Stallmann-Jorgensen IS, Pollock
NK, Harris RA, Keeton D, Huang Y, Li K, Bassali R, Guo DH, Thomas
J, et al: A 16-week randomized clinical trial of 2000 international
units daily vitamin D3 supplementation in black youth:
25-hydroxyvitamin D, adiposity, and arterial stiffness. J Clin
Endocrinol Metab. 95:4584–4591. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Atabek ME, Eklioglu BS, Akyürek N and Alp
H: Association between vitamin D level and cardiovascular risk in
obese children and adolescents. J Pediatr Endocrinol Metab.
27:661–666. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ashraf AP, Alvarez JA, Gower BA, Saenz KH
and McCormick KL: Associations of serum 25-hydroxyvitamin D and
components of the metabolic syndrome in obese adolescent females.
Obesity (Silver Spring). 19:2214–2221. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Aypak C, Türedi O and Yüce A: The
association of vitamin D status with cardiometabolic risk factors,
obesity and puberty in children. Eur J Pediatr. 173:367–373. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gaita D, Mihaescu A and Schiller A: Of
heart and kidney: A complicated love story. Eur J Prev Cardiol.
21:840–846. 2014. View Article : Google Scholar : PubMed/NCBI
|
